PerioTrap Pharmaceuticals
Latest round
- Seed
Last raised
- Aug 2020
Total raised
- $3.5M
Investors
- 3
About PerioTrap Pharmaceuticals
Founded in 2018 and based in Halle, Germany, PerioTrap Pharmaceuticals GmbH develops a small-molecule treatment for gum disease called periodontitis. The treatment targets the bacteria that cause the disease without disrupting the commensal bacteria.
Who invested in PerioTrap Pharmaceuticals
3 investors across 1 round
See all investors in PerioTrap Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 5, 2020
Amount
$3.5M
Investors
Questions about PerioTrap Pharmaceuticals
Who invested in PerioTrap Pharmaceuticals?
PerioTrap Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PerioTrap Pharmaceuticals raised?
PerioTrap Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PerioTrap Pharmaceuticals last raise money?
PerioTrap Pharmaceuticals's most recent round on record is a Seed, in Aug 2020.
What does PerioTrap Pharmaceuticals do?
Founded in 2018 and based in Halle, Germany, PerioTrap Pharmaceuticals GmbH develops a small-molecule treatment for gum disease called periodontitis.
Where is PerioTrap Pharmaceuticals headquartered?
PerioTrap Pharmaceuticals is headquartered in Halle, Germany.
Which VCs invest in companies like PerioTrap Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at PerioTrap Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like PerioTrap Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.